Jump to Navigation

Search Results for site

Patient Navigator for Fertility Preservation Website Launched!


Categories: News
A new website has just been launched to provide assistance to young patients wishing to learn about their reproductive options in the midst of a cancer diagnosis. Now patients and their clinicians can go to the new Patient Navigator for Fertility Preservation website, which includes…

Brain Tumor Community Rallies Around Website

By: Oncofertility Admin -
Categories: Blog, General
I recently had a conversation with Jill de Bartok, the program manager for patient services at the National Brain Tumor Society (NBTS), about their ever-growing programs. NBTS funds cutting-edge science and serves as a resource for researchers and medical professionals.  It also provides services for…

Register Now: The 15th Annual Conference of the Oncofertility Consortium, November 6-8, 2023


Categories: News
We welcome you to the 15th Annual Conference of the Oncofertility Consortium, November 6-8, 2023, that will be hosted again by the Magee-Womens Research Institute & Foundation at The Westin Pittsburgh, PA, USA. For registration, agenda, hotel reservation, abstract submission, sponsorship opportunities & FAQs, please visit the official website…

A New Oncofertility Initiative: Take Charge


Categories: News
Thinking through your fertility options now will help you create the family you want later. Whether you’re a cancer patient, partner, or parent of a cancer patient, Take Charge Initiative can help. Please visit the initiative website to get all the information you need: https://mycancerfertility.org/

Oncofertility Pioneer Prof. Woodruff named as Interim President of Michigan State University


Categories: News
The Oncofertility Consortium congratulates our founder Prof. Teresa K. Woodruff, Ph.D. for being named Interim President of Michigan State University (MSU).  Currently, Dr. Woodruff is also a Foundation Professor in both the Department of Obstetrics, Gynecology, and Reproductive Biology and the Department of Biomedical Engineering at MSU’s College of…

Recordings from the 14th Annual Conference 2022


Categories: News
Over 240 attendees from 15 countries around the globe participated in the 14th Annual Conference of Oncofertility Consortium May 2-4, 2022, that was in-person and hosted by the Magee-Women’s Research Institute & Foundation in Pittsburgh, PA, USA. This 3-day meeting was the first opportunity for…

Educators & Students

Oncofertility National Science Education Network (ONSEN) Dr. Teresa Woodruff initiated the Oncofertility National Science Education Network (ONSEN) in an effort to help attract, prepare and retain female high school students in science majors and careers. ONSEN features educational programs in oncofertility that have been developed…

2017 Oncofertility Conference Agenda

Research and Translational Medicine: Meeting the Needs of Cancer Patients and Survivors November 14-16, 2017 Prentice Women’s Hospital 250 E. Superior St., Third Floor Chicago, IL 60611 Tuesday, November 14, 2017 Day 1 Education Sessions Registration and Continental Breakfast (8:30 – 9:00am) Fellow Education (9:00am –…

The 15th Annual Conference of Oncofertility Consortium, Fall 2023

The 15th Annual Conference of the Oncofertility Consortium, November 6-8, 2023, will be hosted again by Magee-Womens Research Institute & Foundation, in Pittsburgh, PA, USA. The Annual Conference provides an accessible platform for international oncofertility leaders and those new to the field to share their perspectives, discoveries, and vision…

Oncofertility Consortium Boards

Founder of Oncofertility Consortium: Teresa K. Woodruff, PhD Director of Oncofertility Consortium: Mahmoud Salama MD, PhD Chairs of Scientific Committees of Oncofertility Consortium: Children & Adolescents Oncofertility (Pediatric Initiative Network; PIN): Lillian R. Meacham, MD Female Oncofertility: Leslie Appiah, MD Male Oncofertility: Kyle Orwig,

Pilot Project Program

As the field of oncofertility continues to advance, the Oncofertility Consortium seeks to support various high-risk, high-gain initiatives in order to facilitate the launch of early-stage ideas into future grant-funded projects. Applications for pilot projects are evaluated each year, with only a few awarded with…

Obstetrical Oncology: Care for the Pregnant Cancer Patient

Considerations should also be made for young women who are pregnant at the time of cancer diagnosis to achieve a healthy pregnancy. By 2002, the incidence of pregnancy-associated breast cancer had increased to 37.4 per 100,000 deliveries, up from 16.0 in 19631. The co-existence of…

Ovarian Tissue Cryopreservation (OTC)

Who are appropriate candidates? Ovarian tissue cryopreservation is usually only considered in certain cases: Patients who do not have time to undergo controlled ovarian stimulation (COS) for embryo or oocyte cryopreservation.  COS is the more mature technology and should be the first-line treatment if time allows. Patients…

Controlled Ovarian Stimulation (COS) – General Information

In general, for women with cancer, controlled ovarian stimulation (COS) for embryo or oocyte cryopreservation is similar to IVF for infertile couples. However, there are some additonal considerations in this population: What is the general protocol for COS? Pre-cycle considerations Ovarian reserve testing. A study…
Back To Top